All In Biotech

Drug Trial Radar · NCT03737812

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis

A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis

Last checked: Nov 19, 2026Latest source record: Dec 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 123 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

123

Actual

Start

Feb 27, 2019

Primary completion

Jan 15, 2021

Study completion Aug 30, 2021

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Nov 13, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and efficacy of elezanumab in participants with progressive Multiple Sclerosis (PMS).

Conditions

  • Multiple Sclerosis (MS)

Interventions

  • elezanumabDrug

    solution for infusion

  • placeboDrug

    solution for infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Overall Response Score (ORS)Time frame: Week 52

Locations

37 sites in 2 countries. Site status is shown where the registry gives one.

  • St. Josephs Hospital and Med Center /ID# 202809

    Phoenix, Arizona

  • Sutter East Bay Medical Foundation-Jordon Research and Education Dev. Inst. /ID# 202448

    Berkeley, California

  • The Research Center of Southern California /ID# 202802

    Carlsbad, California

  • Vladimir Royter MD /ID# 202483

    Hanford, California

  • Stanford MS Center /ID# 202445

    Palo Alto, California

  • UC Davis Health-Neurological Surgery /ID# 202485

    Sacramento, California

  • UCSF School of Medicine - Neurology /ID# 203194

    San Francisco, California

  • University of Colorado School of Medicine, Dept of Neurology /ID# 202807

    Aurora, Colorado

  • Advanced Neurosciences Research, LLC /ID# 203072

    Fort Collins, Colorado

  • Rowe Neurology Institute /ID# 202744

    Lenexa, Kansas

  • Duplicate_Parexel International /ID# 202747

    Baltimore, Maryland

  • International Neurorehabilitation Institute /ID# 213333

    Lutherville, Maryland

  • Michigan Institute for Neurological Disorders (MIND) /ID# 202470

    Farmington Hills, Michigan

  • Memorial Neurological Institute and Center for Multiple Sclerosis /ID# 206327

    Owosso, Michigan

  • Ridgeview Specialty Clinic Chaska - Neurology /ID# 204384

    Chaska, Minnesota

  • Washington University-School of Medicine /ID# 202899

    St Louis, Missouri

  • The MS Center for Innovations in Care at Missouri Baptist Medical Center /ID# 205432

    St Louis, Missouri

  • Cleveland Clinic Lou Ruvo Cent /ID# 204744

    Las Vegas, Nevada

  • Oklahoma Med Res. Foundation /ID# 203442

    Oklahoma City, Oklahoma

  • Providence Neurological Specialties - West /ID# 203193

    Portland, Oregon

  • Advanced Neurosciences Institute /ID# 204555

    Franklin, Tennessee

  • KCA Neurology - Franklin /ID# 202912

    Franklin, Tennessee

  • Neurology Consultants of Dallas - LBJ Fwy /ID# 203102

    Dallas, Texas

  • Central Texas Neurology Consul /ID# 203108

    Round Rock, Texas

  • Integrated Neurology Services /ID# 202743

    Alexandria, Virginia

  • Evergreen Neuroscience Institute /ID# 204205

    Kirkland, Washington

  • Virginia Mason Medical Center /ID# 205439

    Seattle, Washington

  • Swedish MS Center /ID# 202904

    Seattle, Washington

  • West Virginia Univ School Med /ID# 202849

    Morgantown, West Virginia

  • Froedtert Memorial Lutheran Hospital /ID# 202618

    Milwaukee, Wisconsin

  • University of British Columbia - MS & NMO Clinical Trials Group, Djavad Mowafagh /ID# 203536

    Vancouver, British Columbia, Canada

  • Duplicate_London Health Sciences Centre - University Hospital /ID# 203538

    London, Ontario, Canada

  • Ottawa Hospital Research Institute /ID# 203058

    Ottawa, Ontario, Canada

  • Unity Health Toronto - St. Michael's Hospital /ID# 206213

    Toronto, Ontario, Canada

  • Recherche Sepmus Inc. /ID# 212852

    Greenfield Park, Quebec, Canada

  • Centre Hospitalier de l'Universite de Montreal - CRCHUM /ID# 203869

    Montreal, Quebec, Canada

  • Montreal Neurological Institut /ID# 203868

    Montreal, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.